Indivior PLC Logo

Indivior PLC

Pharmaceutical company developing medicines for substance use and mental disorders.

INDV | IL

Overview

Corporate Details

ISIN(s):
GB00BN4HT335 (+2 more)
LEI:
213800V3NCQTY7IED471
Country:
United Kingdom
Address:
234 BATH ROAD, SL1 4EE SLOUGH

Description

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-24 16:52
Holding(s) in Company
English 23.4 KB
2025-07-24 09:34
Holding(s) in Company
English 25.1 KB
2025-07-23 09:08
Holding(s) in Company
English 25.1 KB
2025-07-21 17:23
Holding(s) in Company
English 25.1 KB
2025-07-21 09:33
Holding(s) in Company
English 25.1 KB
2025-07-18 09:35
Holding(s) in Company
English 25.2 KB
2025-07-17 15:00
Notice of Results
English 10.6 KB
2025-07-01 09:43
Holding(s) in Company
English 56.2 KB
2025-07-01 08:49
Total Voting Rights
English 4.8 KB
2025-06-30 08:00
Indivior Announces Inclusion in US Russell Indexes
English 12.9 KB
2025-06-25 08:00
Indivior Appoints Tony Kingsley to the Board
English 14.0 KB
2025-06-17 17:42
Holding(s) in Company
English 26.7 KB
2025-06-13 09:10
Director/PDMR Shareholding - Correction
English 28.2 KB
2025-06-12 17:24
Director/PDMR Shareholding
English 26.9 KB
2025-06-10 17:12
Holding(s) in Company
English 26.8 KB

Automate Your Workflow. Get a real-time feed of all Indivior PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Indivior PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Indivior PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BioLineRx Ltd. Logo
A clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases.
Israel
BLRX
BIOMARIN PHARMACEUTICAL INC Logo
A global biotechnology company developing therapies for rare, life-threatening genetic diseases.
United States of America
BMRN
BioMaxima S.A. Logo
Manufacturer and distributor of in-vitro diagnostics for clinical microbiology.
Poland
BMX
Biomea Fusion, Inc. Logo
A clinical-stage biopharma developing oral drugs for diabetes and obesity.
United States of America
BMEA
BIOMERICA INC Logo
Develops in-vitro diagnostic and therapeutic products for chronic diseases.
United States of America
BMRA
bioMérieux Logo
A global leader in in vitro diagnostics for clinical and industrial applications.
France
BIM
BiomX Inc. Logo
Clinical-stage company developing phage therapies to target harmful bacteria.
United States of America
PHGE
BIONEERCORPORATION Logo
Develops and manufactures molecular biology products for research and diagnostics.
South Korea
064550
BioNTech SE Logo
Biotechnology company developing immunotherapies for cancer and infectious diseases.
United States of America
BNTX
BioPorto Logo
An in vitro diagnostics company specializing in biomarkers for early kidney injury detection.
Denmark
BIOPOR

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.